Search Results - "Nijenhuis, Dennis N. L. M."

Secretome and immune cell attraction analysis of head and neck cancers by Muijlwijk, Tara, Wondergem, Niels E., Ekhlas, Fatima, Remkes, Naomi, Nijenhuis, Dennis N. L. M., Fritz, Lennart, Ganzevles, Sonja H., Miedema, Iris H. C., Leemans, C. René, Poell, Jos B., Brakenhoff, Ruud H., van de Ven, Rieneke

“…Immune checkpoint inhibitors are approved for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) but the response rate is only 13–18%. For an…”
Get full text

Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites by Muijlwijk, Tara, Nijenhuis, Dennis N L M, Ganzevles, Sonja H, Brink, Arjen, Ke, Changlin, Fass, Joseph N, Rajamanickam, Venkatesh, Leemans, C René, Koguchi, Yoshinobu, Fox, Bernard A, Poell, Jos B, Brakenhoff, Ruud H, van de Ven, Rieneke

“…BackgroundThe response rate to immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) receptor is 13%–18% for patients with recurrent or…”
Get full text

Immune cell topography of head and neck cancer by Muijlwijk, Tara, Nijenhuis, Dennis N L M, Ganzevles, Sonja H, Ekhlas, Fatima, Ballesteros-Merino, Carmen, Peferoen, Laura A N, Bloemena, Elisabeth, Fox, Bernard A, Poell, Jos B, Leemans, C René, Brakenhoff, Ruud H, van de Ven, Rieneke

“…BackgroundApproximately 50% of head and neck squamous cell carcinomas (HNSCC) recur after treatment with curative intent. Immune checkpoint inhibitors are…”
Get full text

At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma by Wondergem, Niels E, Nijenhuis, Dennis N L M, Poell, Jos B, Leemans, C René, Brakenhoff, Ruud H, van de Ven, Rieneke

“…Recent advances in immunotherapy for head and neck squamous cell carcinoma (HNSCC) have led to implementation of anti-programmed death receptor 1 (PD-1)…”
Get full text